Ahn R. Lee
2660 Oak Street
Vancouver, BC, Canada
Vancouver, BC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Corrigendum to "A novel mechanism of SRRM4 in promoting neuroendocrine prostate cancer development via a pluripotency gene network" EBioMedicine 2018 Sep: 35: 167-177.
Journal: EBioMedicine
Published: November 23, 2025
Corrigendum to "RNA Splicing of the BHC80 Gene Contributes to Neuroendocrine Prostate Cancer Progression" [Eur. Urol. 76(2) (2019) 157-166].
Journal: European urology
Published: May 08, 2025
Discovery of New Catalytic Topoisomerase II Inhibitors for Anticancer Therapeutics.
Journal: Frontiers in oncology
Published: November 24, 2020
Alternative splicing of LSD1+8a in neuroendocrine prostate cancer is mediated by SRRM4.
Journal: Neoplasia (New York, N.Y.)
Published: March 29, 2020
LIN28B promotes the development of neuroendocrine prostate cancer.
Journal: The Journal of clinical investigation
Published: December 05, 2019
Transient Sox9 Expression Facilitates Resistance to Androgen-Targeted Therapy in Prostate Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 14, 2019
RNA Splicing of the BHC80 Gene Contributes to Neuroendocrine Prostate Cancer Progression.
Journal: European urology
Published: November 01, 2018
Alternative RNA splicing of the GIT1 gene is associated with neuroendocrine prostate cancer.
Journal: Cancer science
Published: September 26, 2018
Roles of Alternative RNA Splicing of the Bif-1 Gene by SRRM4 During the Development of Treatment-induced Neuroendocrine Prostate Cancer.
Journal: EBioMedicine
Published: February 08, 2018
Development of Neuroendocrine Prostate Cancers by the Ser/Arg Repetitive Matrix 4-Mediated RNA Splicing Network.
Journal: Frontiers in oncology
Published: January 10, 2018
Last Updated: 09/26/2026